Anteis and Sanofi-aventis have entered into a supply and distribution partnership for Succeev, a Hyaluronic Acid (HA) based dermal filler.
Available in Europe, Asia-Pacific, South America and the Middle East, Succeev is a Hyaluronic Acid based dermal filler which includes three formulations, allowing correction of different types of wrinkles and lip augmentation.
Stephane Mendras Anteis, director of business development, said: “Anteis is pleased to be the partner of choice for Sanofi-aventis. Over recent years, Anteis has built its reputation as having unique expertise in the development of hyaluronic acid based products for aesthetic dermatology. This alliance will mean that our highly effective and reliable products will now be available to an even larger group of practitioners and their patients worldwide.”
The partnership comes ahead of a global move from Sanofi-aventis to launch its highly anticipated medical aesthetics business which is expected for January 2010.
Scott McLennan, global marketing medical aesthetics and dermatology franchise manager at Sanofi-aventis, said: “In line with our core business platform, Sanofi-aventis anticipates providing additional sustainable options for healthcare professionals globally, as well as offering more options for patients in all markets.
“Sanofi-aventis has identified a solid opportunity for growth across all the major markets in medical aesthetics.”